Research found that tumor-specific CD8+ T cells cultured under glutamine-restricted (dGln) conditions or adoptive transfer of CD8+ T cells treated with specific inhibitors of glutamine metabolism can effectively eliminate tumors. This evidence concerns the gene CD8A and neoplasm.